Cohort Study | Biomarker trends, incidence, and outcomes of immune checkpoint inhibitor–induced myocarditis

Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis – JACC: CardioOncology

Editorial: Biomarkers for Immune Checkpoint Inhibitor–Induced Myocarditis: Caution Needed – JACC: CardioOncology

News Release: New biomarker strategy devised to screen for, diagnose deadly heart complication from cancer treatment – University of Michigan

Commentary: Biomarker Trends of Immune Checkpoint Inhibitor–Induced Myocarditis – American College of Cardiology

Commentary from the author on Twitter

https://twitter.com/Avasbind/status/1605300563369136128